Kaïdre Bendjama

Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial

Fabien Zoulim, Claire Fournier, François Habersetzer et al. · Human Vaccines & Immunotherapeutics · 2019 · 87 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

BERTMHC: improved MHC–peptide class II interaction prediction with transformer and multiple instance learning

Jun Cheng, Kaïdre Bendjama, Karola Rittner et al. · Bioinformatics · 2021 · 78 citations · Full text

Life Sciences, Bioinformatics, Immunology +17

Viral based vaccine TG4010 induces broadening of specific immune response and improves outcome in advanced NSCLC

Caroline Tosch, Bérangère Bastien, Luc Barraud et al. · Journal for ImmunoTherapy of Cancer · 2017 · 66 citations · Full text

Life Sciences, Immunology, Oncology +17

Neoadjuvant Intravenous Oncolytic Vaccinia Virus Therapy Promotes Anticancer Immunity in Patients

Adel Samson, Emma J. West, Jonathan Carmichael et al. · Cancer Immunology Research · 2022 · 50 citations · Full text

Medicine, Immunology, Oncology +17

Sequential administration of MVA-based vaccines and PD-1/PD-L1-blocking antibodies confers measurable benefits on tumor growth and survival: Preclinical studies with MVA-βGal and MVA-MUC1 (TG4010) in a murine tumor model

Christelle Remy‐Ziller, Christine Thioudellet, Julie Hortelano et al. · Human Vaccines & Immunotherapeutics · 2017 · 34 citations · Full text

Life Sciences, Immunology, Oncology +17